Letter to the Editor in response to the article "Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis".
作者信息
Farag Youssef M K, Zheng Zihe, Luo Wenli
机构信息
Akebia Therapeutics, Inc., 245 First Street, Cambridge, MA, 02142, USA.
Akebia Therapeutics, Inc., 245 First Street, Cambridge, MA, 02142, USA.
出版信息
Pharmacol Res. 2021 Jan;163:105213. doi: 10.1016/j.phrs.2020.105213. Epub 2020 Sep 28.
PMID:33002599
Abstract
摘要
Zotero 插件